Initiating Clinical Trials in Italy

October 19, 2017

 

Alpha Tau Medical is now initiating its Alpha DaRT clinical trial at IRST, Italy. The great team at IRST and Prof. Yona Keisari as well as Amnon Gat are excited about this opportunity to study the efficacy of Alpha DaRT in cancer patients suffering from Squamous Cell Carcinoma (SCC) of the skin. The revolutionary radiotherapy treatment enables a highly potent and specific targeting of solid tumors. Clinical trials in Israel showed highly promising results and the team strives to help millions of patients around the world.

 

IRST (Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori) was founded in 2007 and is situated in Meldola, Italy. The Centre is known for its excellent cancer management and research. With specification in Medical Oncology, Nuclear Medicine, Radio-Metabolic and Immunotherapy as well as Radiotherapy, IRST enables a wide range of personalized diagnostic-therapeutic programs to be offered to patients.

 

Italiano

Deutsch

 

Share on Facebook
Share on Twitter
Please reload

Please reload

Featured Posts

Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Management of Medical Devices

1/5
Please reload

Archive
Please reload

Categories
Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

CONTACT US

Are you looking to participate in clinical trials?

Take our self-assessment test to find potentially suitable studies.

For other inquiries, please visit our contact page.